10th Sep 2009 07:00
GW Pharmaceuticals to present at Rodman & Renshaw Annual Global Investment Conference
Porton Down, UK, 10 September 2009: GW Pharmaceuticals plc (AIM: GWP) announces that its Managing Director, Justin Gover, will be presenting at the Rodman & Renshaw Annual Global Investment Conference in New York on Thursday, September 10, 2009 at 3.40 pm EDT (8.40 pm BST).
Investors may access a live webcast of the presentation at www.gwpharm.com on the presentations page under the Investor Relations tab. An archived version of the presentation will be available later that day.
Enquiries:
|
GW Pharmaceuticals plc |
Today: +44 20 7831 3113 |
|
Justin Gover, Managing Director |
Thereafter: + 44 1980 557000 |
|
Financial Dynamics |
Tel: +44 20 7831 3113 |
|
Ben Atwell, John Dineen |
Notes to Editors
About GW
GW was founded in 1998 and listed on the AIM, a market of the London Stock Exchange, in June 2001. Operating under license from the UK Home Office, the company researches and develops cannabinoid pharmaceutical products for patients who suffer from a range of serious ailments, in particular multiple sclerosis and cancer pain. GW has assembled a large in-house scientific team with expertise in cannabinoid science as well as experience in the development of both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW occupies a world leading position in cannabinoids and has developed an extensive international network of the most prominent scientists in the field. For more information, visit www.gwpharm.com
Related Shares:
GWP.L